Rhiniseng

Authorised

This medicine is authorised for use in the European Union

inactivated vaccine to prevent progressive and non-progressive atrophic rhinitis in pigs

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Rhiniseng : EPAR - Summary for the public

Product information

Rhiniseng : EPAR - Product Information

Rhiniseng : EPAR - All Authorised presentations

Product details

• Name of medicine:
  Rhiniseng
• Active substance:
  • inactivated Bordetella bronchiseptica, strain 833CER
  • recombinant type-D Pasteurella-multocida toxin
• International non-proprietary name (INN) or common name:
  inactivated vaccine to prevent progressive and non-progressive atrophic rhinitis in pigs

Pharmacotherapeutic group

Immunologicals

Authorisation details

• EMA product number:
  EMEA/V/C/000160

Assessment history

Changes since initial authorisation of medicine

Rhiniseng : EPAR - Procedural steps taken and scientific information after authorisation

Initial marketing authorisation documents

Rhiniseng : EPAR - Scientific Discussion

Reference Number: EMA/CVMP/493521/2010

Rhiniseng : EPAR - Procedural steps taken before authorisation

Reference Number: EMA/544561/2010

Committee for Medicinal Products for Veterinary Use positive summary of opinion for Rhiniseng

Adopted Reference Number: EMA/403480/2010